TGFB1 and cancer: Another strategy to prevent extracellular matrix stiffness involves the use of antifibrotics that repress collagen synthesis and maturation by inhibiting SMAD3 with halofuginone or TGFβ with pirfenidon or losartan in cancer-associated fibroblasts, the major producers of collagen.